Kidney

 

 

Kidney Cancer Highlights

The surgical and medical treatment of renal cell carcinoma (RCC) has
changed dramatically in the last several years and continues to constantly
evolve. This kidney cancer webcast series intends to educate the
audience regarding the management of the complete spectrum of kidney
cancer patients; from small renal masses through metastatic disease. 
The talks included in the webcast will elucidate the established principles
to guide treatment decisions in this group of patients as well as newer
data and areas of disagreement and controversy. It is our hope that you
will find this session informative and up to date regarding all aspects of kidney cancer management.

Print this Content
Current Role of Cytoreductive Nephrectomy
Estimated Time: 45 minutes
Release Date: 01/21/09
Type: Webcast
Technical Requirements: Windows Media
Expiration Date: 01/21/10
Specialties: Nephrology, Urology, Oncology
Initial Systemic Therapy Options
Estimated Time: 1 hour
Release Date: 01/21/09
Type: Webcast
Technical Requirements: Windows Media
Expiration Date: 01/21/10
Specialties: Nephrology, Urology, Oncology
Management of Small Renal Masses: The Role of Percutaneous Biopsy
Estimated Time: 45 minutes
Release Date: 01/21/09
Type: Webcast
Technical Requirements: Windows Media
Expiration Date: 01/21/10
Specialties: Nephrology, Urology, Oncology
Management of Small Renal Masses: What is the Best Management Option in this Case?
Estimated Time: 1 hour
Release Date: 01/21/09
Type: Webcast
Technical Requirements: Windows Media
Expiration Date: 01/21/10
Specialties: Nephrology, Urology, Oncology

Series Objectives

On completion of this educational series, participants will be able to:

  1. Review the biology of renal cell carcinoma.
  2. Discuss the role of renal biopsy.
  3. Discuss various management options for small renal masses.
  4. Describe the current systemic treatment options in metastatic renal cell carcinoma.

Accreditation

These activities have been approved for AMA PRA Category 1 Credit™.

 

Target Audience

These activities are directed to medical oncologists and urologists.

Activity Director

Brian Rini, MD
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH

 

Planning Committee

Thomas Hutson, D.O., PharmD.
Texas Oncology, PA
Baylor Sammons Cancer Center
Dallas, TX

Christopher Wood, M.D., FACS
M.D. Anderson Cancer Center
Houston, TX

 
Copyright © 2000-2019 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124
Copyright © 2000-2019 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124